Certara Inc. (CERT)
10.76
-0.21 (-1.91%)
At close: Jan 14, 2025, 3:59 PM
10.70
-0.51%
After-hours Jan 14, 2025, 06:23 PM EST
undefined% (undefined)
| Bid | 10.41 |
| Market Cap | 1.73B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -53.77 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 12.01 |
| Volume | 673,522 |
| Avg. Volume (20D) | 1,192,140 |
| Open | 11.02 |
| Previous Close | 10.97 |
| Day's Range | 10.47 - 11.14 |
| 52-Week Range | 9.41 - 19.87 |
| Beta | undefined |
About CERT
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulator...
Sector Healthcare
IPO Date Dec 11, 2020
Employees 1,338
Stock Exchange NASDAQ
Ticker Symbol CERT
Website https://www.certara.com
Analyst Forecast
According to 7 analyst ratings, the average rating for CERT stock is "Hold." The 12-month stock price forecast is $15.75, which is an increase of 46.44% from the latest price.
Buy 28.57%
Hold 71.43%
Sell 0.00%
Next Earnings Release
Certara Inc. is scheduled to release its earnings on Feb 27, 2025,
during market hours.
Analysts project revenue of $98.26M, reflecting a 11.65% YoY growth and earnings per share of 0.12, making a 33.33% increase YoY.
Analysts project revenue of $98.26M, reflecting a 11.65% YoY growth and earnings per share of 0.12, making a 33.33% increase YoY.
3 months ago ·
Source
+9.81%
Certera shares are trading higher after UBS upgrad...
Unlock content with
Pro Subscription
5 months ago ·
Source
-13.59%
Certara shares are trading lower after the company reported worse-than-expected Q2 financial results.
